Phase 3
Completed N=263
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
Cataract Extraction
Source: ClinicalTrials.gov NCT00521456 ↗
Enrolled (actual)
263
Serious AEs
—
Results posted
Oct 2009
Primary outcomePrimary: Resolution of Post Operative Inflammation — 58.0; 27.3 % of participants with a score of 0
Summary
This is a 16 day study to evaluate the safety and efficacy of ketorolac eye drops for the treatment of inflammation and pain associated with cataract surgery
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Resolution of Post Operative Inflammation |
58.0; 27.3 | — |
| SECONDARY Ocular Pain |
70.0; 38.5 | — |
| SECONDARY Mean Pupil Area |
37.9; 36.5 | — |
Eligibility Criteria
Inclusion Criteria
- Patients undergoing cataract surgery
Exclusion Criteria
- Uncontrolled ocular disease in cataract surgery eye
Data sourced from ClinicalTrials.gov (NCT00521456). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.